Innovative Food Financials
This page shows Innovative Food (IVFH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Profitability improved through a leaner cost base, as overhead discipline let a roughly flat sales level support operating income.
The clearest earnings-quality shift is between adjacent years: net income of$2.6M was paired with operating cash flow of-$6.3M , showing profit that depended more on noncash or working-capital effects than cash conversion. The next year the mismatch reversed—net income was-$2.0M , but operating income reached$2.6M and cash burn was nearly gone, implying core operations strengthened even as the reported loss looked worse.
This looks like a cost-led turnaround, not a volume-led one: revenue still sits below its earlier peak, so the improvement reflects a lower fixed overhead burden rather than broader demand alone. SG&A is down by about
Leverage has been taken down sharply, with long-term debt cut from
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Innovative Food's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Innovative Food has an operating margin of 4.3%, meaning the company retains $4 of operating profit per $100 of revenue. This below-average margin results in a low score of 27/100, suggesting thin profitability after operating expenses. This is up from 2.1% the prior year.
Innovative Food's revenue grew a modest 2.1% year-over-year to $60.7M. This slow but positive growth earns a score of 21/100.
Innovative Food carries a low D/E ratio of 0.03, meaning only $0.03 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Innovative Food's current ratio of 1.35 is below the typical benchmark, resulting in a score of 22/100. This tight liquidity could limit financial flexibility if cash inflows slow.
While Innovative Food generated -$27K in operating cash flow, capex of $242K consumed most of it, leaving -$270K in free cash flow. This results in a low score of 16/100, reflecting heavy capital investment rather than weak cash generation.
Innovative Food generates a -32.1% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from 31.8% the prior year.
Innovative Food scores 1.76, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Innovative Food passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Innovative Food generates $0.01 in operating cash flow (-$27K OCF vs -$2.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Innovative Food earns $87.0 in operating income for every $1 of interest expense ($2.6M vs $30K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Innovative Food generated $60.7M in revenue in fiscal year 2025. This represents an increase of 2.1% from the prior year.
Innovative Food's EBITDA was $3.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 95.0% from the prior year.
Innovative Food reported -$2.0M in net income in fiscal year 2025. This represents a decrease of 176.9% from the prior year.
Innovative Food earned $0.05 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 43.2% from the prior year.
Cash & Balance Sheet
Innovative Food generated -$270K in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 95.9% from the prior year.
Innovative Food held $927K in cash against $217K in long-term debt as of fiscal year 2025.
Innovative Food had 55M shares outstanding in fiscal year 2025. This represents an increase of 2.8% from the prior year.
Margins & Returns
Innovative Food's gross margin was 25.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.5 percentage points from the prior year.
Innovative Food's operating margin was 4.3% in fiscal year 2025, reflecting core business profitability. This is up 2.2 percentage points from the prior year.
Innovative Food's net profit margin was -3.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 7.7 percentage points from the prior year.
Innovative Food's ROE was -32.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 63.9 percentage points from the prior year.
Capital Allocation
Innovative Food invested $242K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 23.5% from the prior year.
IVFH Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.2M+49.9% | $8.1M-50.5% | $16.4M-22.2% | $21.1M+40.4% | $15.0M+31.4% | $11.4M-27.9% | $15.9M-4.6% | $16.6M |
| Cost of Revenue | $9.1M+92.4% | $4.7M-62.5% | $12.6M-24.6% | $16.7M+50.1% | $11.1M+41.0% | $7.9M-35.4% | $12.2M-3.5% | $12.6M |
| Gross Profit | $3.1M-8.7% | $3.4M-11.3% | $3.9M-13.0% | $4.4M+13.1% | $3.9M+10.0% | $3.6M-3.0% | $3.7M-7.8% | $4.0M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $2.8M+42.0% | $2.0M-38.9% | $3.2M-23.8% | $4.2M+14.5% | $3.7M+17.5% | $3.1M+10.3% | $2.8M-26.4% | $3.8M |
| Operating Income | $351K-76.1% | $1.5M+121.2% | $663K+171.3% | $245K-6.1% | $260K-42.0% | $449K-47.1% | $849K+475.5% | $148K |
| Interest Expense | $7K+104.1% | -$180K-1275.4% | $15K-91.9% | $188K+2731.5% | $7K+101.5% | -$455K-3828.6% | -$12K-105.5% | $209K |
| Income Tax | $0-100.0% | $81K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $1.8M+1919.6% | $91K+105.3% | -$1.7M-3038.3% | $59K+113.6% | -$430K-650.1% | -$57K-104.3% | $1.3M+1391.9% | -$103K |
| EPS (Diluted) | $0.01 | N/A | $0.01+1100.0% | $0.00-80.0% | $0.01 | N/A | $0.02+1800.0% | $-0.00 |
IVFH Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.1M-38.1% | $19.6M-7.1% | $21.1M-12.1% | $24.0M-4.6% | $25.1M-8.1% | $27.3M+28.9% | $21.2M+7.8% | $19.7M |
| Current Assets | $9.8M-41.7% | $16.8M-9.8% | $18.6M-9.9% | $20.7M-4.8% | $21.7M-9.2% | $23.9M+23.3% | $19.4M+7.2% | $18.1M |
| Cash & Equivalents | $1.2M+32.7% | $927K+35.5% | $684K-56.0% | $1.6M+40.6% | $1.1M-13.5% | $1.3M-73.5% | $4.8M+24.7% | $3.9M |
| Inventory | $3.1M-9.9% | $3.5M-18.2% | $4.2M-28.0% | $5.9M-13.2% | $6.8M+93.7% | $3.5M+11.9% | $3.1M+13.5% | $2.8M |
| Accounts Receivable | $5.3M+0.1% | $5.3M+1.8% | $5.2M-24.7% | $6.9M-7.7% | $7.5M+27.8% | $5.9M+18.1% | $5.0M-4.5% | $5.2M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $4.0M-70.0% | $13.3M-8.8% | $14.6M-8.3% | $16.0M-7.6% | $17.3M-9.8% | $19.2M+24.1% | $15.5M+0.7% | $15.4M |
| Current Liabilities | $3.3M-73.9% | $12.4M-8.8% | $13.6M+108.3% | $6.5M-15.4% | $7.7M-17.8% | $9.4M+46.5% | $6.4M+4.0% | $6.2M |
| Long-Term Debt | $200K-8.0% | $217K-7.1% | $234K-97.3% | $8.6M-0.7% | $8.7M+2961.8% | $283K-96.6% | $8.4M-0.3% | $8.5M |
| Total Equity | $8.1M+29.9% | $6.2M-3.2% | $6.4M-19.5% | $8.0M+2.0% | $7.8M-4.0% | $8.2M+42.0% | $5.8M+33.4% | $4.3M |
| Retained Earnings | -$36.4M+4.8% | -$38.3M+0.1% | -$38.3M-4.7% | -$36.6M+0.2% | -$36.6M-1.2% | -$36.2M-0.1% | -$36.2M+3.6% | -$37.5M |
IVFH Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$234K-135.4% | $660K+331.4% | -$285K-149.6% | $575K+158.8% | -$977K+72.5% | -$3.6M-564.1% | $766K+334.9% | -$326K |
| Capital Expenditures | $31K+139.1% | $13K-36.0% | $20K-55.2% | $46K-72.1% | $163K+2136.4% | $7K-97.5% | $293K+1930.3% | $14K |
| Free Cash Flow | -$265K-140.9% | $647K+311.7% | -$306K-157.7% | $530K+146.4% | -$1.1M+68.0% | -$3.6M-853.9% | $472K+238.8% | -$340K |
| Investing Cash Flow | $8.8M+67266.4% | -$13K-138.2% | $34K+174.9% | -$46K+72.1% | -$163K+85.2% | -$1.1M-577.0% | $232K+1702.6% | -$14K |
| Financing Cash Flow | -$8.8M-1183.6% | -$686K-367.8% | $256K+414.8% | -$81K+39.4% | -$134K-106.0% | $2.2M+3645.9% | -$63K+4.8% | -$66K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
IVFH Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 25.6%-16.4pp | 42.1%+18.6pp | 23.5%+2.5pp | 21.0%-5.1pp | 26.1%-5.0pp | 31.1%+8.0pp | 23.1%-0.8pp | 23.9% |
| Operating Margin | 2.9%-15.2pp | 18.1%+14.0pp | 4.0%+2.9pp | 1.2%-0.6pp | 1.7%-2.2pp | 3.9%-1.4pp | 5.3%+4.5pp | 0.9% |
| Net Margin | 15.1%+14.0pp | 1.1%+11.6pp | -10.5%-10.8pp | 0.3%+3.1pp | -2.9%-2.4pp | -0.5%-8.9pp | 8.4%+9.0pp | -0.6% |
| Return on Equity | 22.7%+21.3pp | 1.5%+28.1pp | -26.7%-27.4pp | 0.7%+6.2pp | -5.5%-4.8pp | -0.7%-23.9pp | 23.2%+25.6pp | -2.4% |
| Return on Assets | 15.2%+14.7pp | 0.5%+8.6pp | -8.2%-8.4pp | 0.2%+1.9pp | -1.7%-1.5pp | -0.2%-6.5pp | 6.3%+6.8pp | -0.5% |
| Current Ratio | 3.01+1.7 | 1.35-0.0 | 1.36-1.8 | 3.15+0.4 | 2.80+0.3 | 2.54-0.5 | 3.02+0.1 | 2.93 |
| Debt-to-Equity | 0.02-0.0 | 0.030.0 | 0.04-1.0 | 1.07-0.0 | 1.10+1.1 | 0.03-1.4 | 1.47-0.5 | 1.96 |
| FCF Margin | -2.2%-10.1pp | 8.0%+9.8pp | -1.9%-4.4pp | 2.5%+10.1pp | -7.6%+23.6pp | -31.1%-34.1pp | 3.0%+5.0pp | -2.1% |
Similar Companies
Frequently Asked Questions
What is Innovative Food's annual revenue?
Innovative Food (IVFH) reported $60.7M in total revenue for fiscal year 2025. This represents a 2.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Innovative Food's revenue growing?
Innovative Food (IVFH) revenue grew by 2.1% year-over-year, from $59.4M to $60.7M in fiscal year 2025.
Is Innovative Food profitable?
No, Innovative Food (IVFH) reported a net income of -$2.0M in fiscal year 2025, with a net profit margin of -3.3%.
What is Innovative Food's EBITDA?
Innovative Food (IVFH) had EBITDA of $3.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Innovative Food have?
As of fiscal year 2025, Innovative Food (IVFH) had $927K in cash and equivalents against $217K in long-term debt.
What is Innovative Food's gross margin?
Innovative Food (IVFH) had a gross margin of 25.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Innovative Food's operating margin?
Innovative Food (IVFH) had an operating margin of 4.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Innovative Food's net profit margin?
Innovative Food (IVFH) had a net profit margin of -3.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Innovative Food's return on equity (ROE)?
Innovative Food (IVFH) has a return on equity of -32.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Innovative Food's free cash flow?
Innovative Food (IVFH) generated -$270K in free cash flow during fiscal year 2025. This represents a 95.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Innovative Food's operating cash flow?
Innovative Food (IVFH) generated -$27K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Innovative Food's total assets?
Innovative Food (IVFH) had $19.6M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Innovative Food's capital expenditures?
Innovative Food (IVFH) invested $242K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Innovative Food's current ratio?
Innovative Food (IVFH) had a current ratio of 1.35 as of fiscal year 2025, which is considered adequate.
What is Innovative Food's debt-to-equity ratio?
Innovative Food (IVFH) had a debt-to-equity ratio of 0.03 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Innovative Food's return on assets (ROA)?
Innovative Food (IVFH) had a return on assets of -10.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Innovative Food's cash runway?
Based on fiscal year 2025 data, Innovative Food (IVFH) had $927K in cash against an annual operating cash burn of $27K. This gives an estimated cash runway of approximately 407 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Innovative Food's Altman Z-Score?
Innovative Food (IVFH) has an Altman Z-Score of 1.76, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Innovative Food's Piotroski F-Score?
Innovative Food (IVFH) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Innovative Food's earnings high quality?
Innovative Food (IVFH) has an earnings quality ratio of 0.01x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Innovative Food cover its interest payments?
Innovative Food (IVFH) has an interest coverage ratio of 87.0x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Innovative Food?
Innovative Food (IVFH) scores 31 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.